After formerly obtaining a regulatory for patients over 18 years old, Hedia can now expand its support to pediatric care.

Five patients have so far been treated with Anocca’s in-house developed TCR-T cell therapy for pancreatic cancer, with the latest becoming the first patient in Sweden. The Södertälje-based company is ...

The US Food and Drug Administration (FDA) has approved a surgically implanted heart valve for children with a special feature: it can be expanded as the child grows.

Despite meeting both primary endpoints in a Phase 3 trial of the obesity drug survodutide, Zealand Pharma’s shares fell sharply on Thursday.

After years of success with the injection based Wegovy, Novo has released it in pill form in a wide range of countries – but ...

Swedish biotech company Empros Pharma is discontinuing its obesity drug programme. Difficulties in securing funding and ...

Sanofi and Regeneron are stepping up their long-standing partnership. The companies are now investing in four new antibody ...

German pharmaceutical company Biontech will close its facilities in Tübingen, Marburg and Idar-Oberstein after failing to ...

One in three Swedish infants have no detectable levels of a bacterium that helps support the developing immune system, according to a new Swedish study. The figure is notably high compared with ...

A successful Phase III trial in age-related macular degeneration sent shares in US-based Kodiak Sciences soaring on Monday.

An Alzheimer’s research project led by associate professor Sebastian Palmqvist at Lund University has been awarded 19.4 ...

MEMBER ANNOUNCEMENT - Many innovative therapies and medical technologies face the same challenge: you know a clinical study ...